GuideAI Health Company Profile

Background

Overview

GuideAI Health, founded in 2024, is a Boston-based company dedicated to enhancing the early detection and diagnosis of chronic vascular diseases through advanced artificial intelligence (AI) technologies. The company focuses on addressing the challenges in identifying subtle disease markers in medical imaging, particularly for peripheral vascular disease (PVD), which affects approximately 230 million individuals worldwide.

Mission and Vision

The mission of GuideAI Health is to improve patient outcomes by enabling earlier and more effective diagnosis and treatment of chronic vascular diseases. By leveraging AI to detect subtle disease markers often missed by the human eye, the company aims to prevent adverse cardiovascular events, amputations, and reduce long-term healthcare costs.

Industry Significance

In the healthcare sector, early detection of vascular diseases is critical for preventing severe complications. GuideAI Health's innovative approach positions it as a significant contributor to improving diagnostic precision and patient care in the field of vascular health.

Key Strategic Focus

Core Objectives

Early Detection: Utilize AI to identify subtle markers of vascular diseases in medical imaging, enabling timely intervention.

Diagnostic Precision: Enhance the accuracy of diagnoses to prevent adverse cardiovascular events and reduce healthcare costs.

Workflow Efficiency: Integrate AI solutions into existing radiology workflows to improve efficiency and reduce radiologist burnout.

Areas of Specialization

GuideAI Health specializes in AI-driven solutions for the early detection and management of chronic vascular diseases, with a particular focus on PVD.

Key Technologies Utilized

Artificial Intelligence and Machine Learning: Develop advanced models to analyze medical imaging data for disease detection.

Medical Imaging Analysis: Employ AI to interpret CT scans and other imaging modalities for vascular health assessment.

Primary Markets Targeted

Radiology Practices: Enhance diagnostic precision and workflow efficiency.

Hospitals and Physicians: Identify and treat PVD patients with appropriate care.

Medical Device Companies: Leverage real-time access to disease prevalence data.

Financials and Funding

Funding History

As of March 2026, GuideAI Health has not publicly disclosed specific funding details.

Recent Funding Rounds

The company has not announced any recent funding rounds.

Notable Investors

Investor information is not publicly available.

Utilization of Capital

GuideAI Health plans to utilize capital to further develop its AI-powered platform, expand its market presence, and enhance its product offerings.

Pipeline Development

Key Pipeline Candidates

GuideAI Health's primary product is VascularAssist, an AI-powered platform designed for the early detection and management of chronic vascular diseases.

Stages of Development

VascularAssist is currently in the market, offering AI-driven solutions for vascular disease detection.

Target Conditions

The platform focuses on peripheral vascular disease (PVD), aiming to improve early detection and treatment outcomes.

Anticipated Milestones

GuideAI Health plans to expand the capabilities of VascularAssist and integrate it into more healthcare settings to enhance diagnostic precision and patient care.

Technological Platform and Innovation

Proprietary Technologies

VascularAssist Platform: An AI-driven solution for analyzing medical imaging data to detect vascular diseases.

Significant Scientific Methods

AI and Machine Learning Algorithms: Utilized to interpret complex imaging data and identify subtle disease markers.

AI-Driven Capabilities

Automated Image Analysis: Enables rapid and accurate detection of vascular abnormalities.

Predictive Diagnostics: Assists healthcare providers in making informed decisions for patient care.

Leadership Team

Raj Shah, MD, MBA – Chief Executive Officer

Dr. Shah is the CEO and co-founder of GuideAI Health. He is a board-certified interventional radiologist with extensive experience in vascular disease management. Dr. Shah holds an MBA and has a strong background in healthcare entrepreneurship.

Luke Higgins, MD, PhD – Chief Medical Officer

Dr. Higgins serves as the Chief Medical Officer. He is a physician-scientist specializing in vascular medicine and has a PhD in biomedical engineering. Dr. Higgins has a track record of research in vascular health and medical device development.

Amin Katouzian, PhD – Chief Technology Officer

Dr. Katouzian is the Chief Technology Officer. He holds a PhD in computer science with a focus on machine learning and AI applications in healthcare. Dr. Katouzian has experience in developing AI solutions for medical diagnostics.

Kourosh Jafari-Khouzani, PhD – Lead Data Scientist

Dr. Jafari-Khouzani is the Lead Data Scientist. He has a PhD in data science and specializes in AI algorithms for medical imaging analysis. Dr. Jafari-Khouzani has contributed to the development of AI models for disease detection.

Gail Marcus, MBA – Strategic Advisor

Ms. Marcus serves as a Strategic Advisor. She holds an MBA and has a background in healthcare strategy and operations. Ms. Marcus has experience in guiding healthcare startups through growth and scaling phases.

James Benenati, MD – Clinical Advisor

Dr. Benenati is the Clinical Advisor. He is a board-certified interventional radiologist with expertise in vascular interventions. Dr. Benenati provides clinical insights to guide the development of GuideAI Health's products.

Alok Gupta, PhD, MBA – Technology Advisor

Dr. Gupta serves as a Technology Advisor. He holds a PhD in computer science and an MBA, with experience in AI technology commercialization in healthcare. Dr. Gupta advises on technology strategy and product development.

Himanshu Choksi, MBA – Business Advisor

Mr. Choksi is the Business Advisor. He holds an MBA and has a background in business development and partnerships in the healthcare sector. Mr. Choksi assists in strategic business initiatives and partnerships.

Market and Competitor Profile

Market Insights and Dynamics

The market for AI-driven healthcare solutions, particularly in the early detection of vascular diseases, is growing rapidly. Advancements in AI and machine learning are driving innovation in medical diagnostics, creating opportunities for companies like GuideAI Health to lead in this space.

Competitor Analysis

GuideAI Health operates in a competitive landscape with several key players:

Elucid: Develops AI-based arterial analysis software for clinical providers.

Good Measures: Offers personalized nutrition and health coaching services.

M Health Fairview: Provides healthcare services with a focus on digital health solutions.

Alchemy Health: Specializes in AI-driven healthcare analytics.

Goodpath: Offers personalized health programs based on AI insights.

Strategic Collaborations and Partnerships

GuideAI Health has established partnerships with leading organizations to enhance its offerings:

Regulatory Consultants: Collaborates with experts to navigate FDA approval processes.

Data Annotation Partners: Works with specialized labs to annotate imaging data for AI model training.

Technology Partners: Engages with tech firms to integrate advanced AI capabilities into its platform.

Operational Insights

GuideAI Health differentiates itself through its AI-driven approach to early disease detection, aiming to improve patient outcomes and reduce healthcare costs. The company's focus on integrating seamlessly into existing healthcare workflows provides a competitive edge in the market.

Strategic Opportunities and Future Directions

GuideAI Health plans to expand its product offerings, enhance AI capabilities, and form additional strategic partnerships to strengthen its market position and drive growth.